Q2 2021 Vitrolife AB Earnings Call Transcript
Good day, and thank you for standing by, and welcome to the interim report January-June 2021. (Operator Instructions)
For your information, the conference is being recorded.
Now I would like to hand the conference over to your speaker, Thomas Axelsson. Please go ahead.
()-
Thank you very much, and welcome to the Interim Report January-June 2021. The speakers today will be Mikael Engblom, he's the CFO of the company; and myself, Thomas Axelsson, that is CEO of the company.
Please change page to them and go into the summary of the Q2. Q2, it was a quarter of good growth. Sales was SEK 382 million, and that was a growth in 83% in Swedish currency. Sales increased by 94% in local currency and the EBITDA with a margin of 39%, excluding onetime cost. I would also within -- together with Mikael in this interim report go through -- and happening after the closing date. And that is the announcement of an agreement to acquire 100% of Igenomix.
Please change page
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
